WIXLIB

James C. GreenwoodPresident & CEOJames C. Greenwood is President and CEO of the Biotechnology Industry Organization(BIO) in Washington, D.C., which represents more than 1,200 biotechnology companies,academic institutions, state biotechnology centers and related organizations across theUnited States and in more than 30 other nations. BIO members are involved in theresearch and development of innovative healthcare, agricultural, industrial andenvironmental biotechnology products. BIO also produces the annual BIO InternationalConvention, the world's largest gathering of the biotechnology industry, along withindustry-leading investor and partnering meetings held around the world.Since his appointment in January of 2005, he has markedly enhanced the tradeassociation’s capacity – increasing both its staff and budget by nearly fifty percent. BIOis now a world class advocacy organization playing a leading role in shaping publicpolicy on a variety of fronts critical to the success of the biotechnology industry at thestate and national levels as well as internationally.Mr. Greenwood represented Pennsylvania's Eighth District in the U.S. House ofRepresentatives from January 1993 through January 2005. A senior member of theEnergy and Commerce Committee, he was widely viewed as a leader on health careand the environment. From 2001 to 2004, Mr. Greenwood served as Chairman of theEnergy and Commerce Committee Subcommittee on Oversight and Investigation withoversight authority over issues in the full Committee's vast jurisdiction. He led hardhitting investigations into corporate governance at Enron, Global Crossing andWorldCom; terrorist threats to our nation's infrastructure; and waste and fraud in federalgovernment agencies.Prior to his election to Congress, Mr. Greenwood served six years in the PennsylvaniaGeneral Assembly (1981-86) and six years in the Pennsylvania Senate (1987-1992). Mr.Greenwood graduated from Dickinson College in 1973 with a BA in Sociology. From1977 until 1980, he worked as a caseworker with abused and neglected children at theBucks County Children and Youth Social Service Agency. Mr. Greenwood is marriedwith three children and resides in Upper Makefield, Pennsylvania.

Andrew CaseyPresident and CEOIn his role as President & CEO of BIOTECanada, Andrew is responsible for the day-today operations of the Association. In this capacity, he is the primary spokesperson forCanada's biotech industry communicating on the industry's behalf with government,regulators, international bodies, media and the Canadian public. He also ensuresBIOTECanada plays a central role in partnership with Government in the development ofpolicy relating to Canada's biotech sector and the member companies of BIOTECanada.Prior to joining BIOTECanada, Andrew served from 2004-2012 as Vice President, PublicAffairs and International Trade and Vice President, Government Relations andCommunications for the Forestry Products Association of Canada. In those roles he heldresponsibility for the Association’s government relations, communications, mediarelations, advertising and international trade undertakings. From 1993-2004 he held theposition of Assistant Vice-President, Government Relations with the Canadian Life andHealth Insurance Association. Between 1989 and 1993 Andrew held political assistantpositions with a Member of Parliament and the Minister of State (Finance).Andrew Casey is a native of Montreal, Quebec. After attending Loyola High School(Montreal) and St. Lawrence CEGEP (Quebec City) he graduated from CarletonUniversity (Ottawa) with a Bachelor of Arts degree in Political Science.Joanna DuPontDirector, Industrial Biotechnology at EuropaBioJoanna Dupont-Inglis first joined EuropaBio, the European Association of Bioindustries,in February 2009 and in April 2011 was appointed Director of Industrial Biotechnology.Her work within EuropaBio focuses on helping to develop a stable, long-term, coherentregulatory framework for dynamic and innovative biobased industries as key enablers ofthe broader EU bioeconomy. In this context EuropaBio seeks a supportive and

competitive EU Common Agricultural Policy, an innovation-driven research program witha focus on Public Private Partnerships and industrial policy to help create marketdemand for smart and sustainable biobased products and processes.Improving understanding of the benefits and solutions provided by industrial biotech intackling grand challenges such as resource efficiency, the need for food, feed and fuel,climate change mitigation and sustainable economic recovery are also a key focus.Dupont-Inglis has an academic background in Environmental Science from theUniversities of Sussex, UK and Nantes, France. Between 2000 and 2009 she worked asa consultant in public affairs and strategic communications with a broad range ofindustries, trade associations and NGOs in Brussels, in the fields of environment,energy, agriculture, health and development. During this time she also worked for LIFE,the financial instrument of DG Environment at the European Commission.Dato’ Dr. Mohd. Nazlee KamalChief Executive Officer of Malaysian Biotechnology Corporation (BiotechCorp)Nazlee was appointed as the Chief Executive Officer of the Malaysian BiotechnologyCorporation (BiotechCorp) in July 2011.With 25 years of diverse industry background inbiotechnology including 10 years of executive management experience, Nazlee brings instrong acumen in both the technical and business aspects of biotechnology. Recognizedfor his wide industrial leadership, Nazlee has played a pivotal role in the formulation ofMalaysia’s National Biotechnology Policy.He currently sits as a Board of Director of BiotechCorp, and as the Chairman of BioXCell Sdn Bhd, a custom-built biotechnology park and ecosystem in Iskandar Malaysiafor industrial and healthcare biotechnology, with a focus on manufacturing and R&D.Nazlee is also one of the Advisory Panel members for Northern Corridor ImplementationAuthority (NCIA) for Plant Science and Tissue Culture Node (PSTCN). This is asubsector in the development of a Centre of Excellence for Agriculture Biotechnologyunder North Corridor Economic Region (NCER) Biotech Initiatives.Nazlee’s qualifications include a PhD. in Chemical Engineering (Bioprocess) fromUniversity of Queensland, Brisbane, Australia, Masters of Applied Science inBiotechnology with 8 Distinctions from University of New South Wales, Australia andB.Sc. in Chemical Engineering with High Scholarship at the Oregon State University,USA. Nazlee has written numerous papers for journals and is called on frequently tospeak on a wide range of topics at conferences nationally and internationally.

Elizabeth FarinaChief Executive Officer, UNICAA professor since 1982 of the Economics Department at FEA, the University of SãoPaulo’s Faculty of Economics, Administration and Accounting, Farina has been Head ofthe Economics Department since 2011. She is a former President of CADE, the BrazilianCompetition Authority, and Vice-Coordinator of PENSA, the University of São Paulo’sAgribusiness Intelligence Center.David LindsayPresident and CEO of FPACDavid Lindsay became the President and CEO of FPAC in September 2012. He wasmost recently a senior Deputy Minister in the Government of Ontario serving in theportfolios of Energy and Infrastructure, Northern Development, Mines and Forestry,Natural Resources, and Tourism and Culture.Before this, he served as President and CEO of the Association of Colleges of AppliedArts and Technology of Ontario. Lindsay was the founding President of the OntarioSuperBuild Corporation and the Ontario Jobs and Investment Board. He also served asPrincipal Secretary and Chief of Staff to the Premier of Ontario.He is a Fellow of the Queen’s University School of Policy Studies and past Director ofthe Ireland Park Foundation, the Ontario Innovation Trust, the World Wildlife Fund, theCanadian Tourism Commission, the Public Policy Forum and the Empire Club ofCanada.A Graduate of Queen’s University School of Business (Commerce ’81), David is marriedto Charmaine and they have two adult children Tim and Sarah.

Mark BüngerResearch DirectorMark Bünger is a Research Director at Lux Research, with over 20 years of businessstrategy experience as a management consultant and technology analyst. In this time,he has advised more than 40 Fortune 500 corporations, led hundreds of engagements,and authored over 60 reports and other publications. He is passionate about scienceand its role in innovation, and works with R&D and business leaders at clients aroundthe world.Mark joined Lux Research in 2005, and launched Lux Research’s Intelligence Servicesin Alternative Fuels and Bio-based Materials & Chemicals; the company’s Consultingpractice; and its internal and external training program, Lux University. He currentlyfocuses on innovation strategies and long-term industry foresight.Prior to joining Lux, Mark was a Principal Analyst at Forrester Research in automotive,aerospace, and manufacturing; a Managing Director at European technologyconsultancy LB International; a co-founder of leading online promotional currencycompany SoftCoin, sold to You Technologies; and a senior consultant at Accenture inthe U.S. and Europe.Mark and his work have figured in leading media outlets in the U.S. and Europe,including CNN, PBS, CNBC, NPR, The Wall Street Journal, the Financial Times, GeneticEngineering and Biotechnology News, American Chemical Society Nano Letters, andother technical, regional, and trade publications and channels. He is a frequent speakerwith recent presentations to the European Commission, the American Association for theAdvancement of Science (AAAS), American Institute of Physics, and other government,academic, and industrial groups.Mark’s business education was in International Business at Mälardalen Polytechnic inSweden, and Market Research at the University of Texas at Austin. His ongoingtechnical education includes extension courses and lab work in neurology andbioengineering at University of California (Berkeley) and San Francisco (UCSF). He hasserved as Chairman and Vice-Chair of the Swedish-American Chamber of Commerceon the regional and national level, respectively.

Paolo CarolloEVP, Chemtex International Inc.Paolo has been Executive Vice President for the company since early 2005, working onseveral assignments including Project Development for innovative technology platforms,Business Development, Finance & Control, and Strategic Planning. Paolo joinedChemtex parent Company M&G Group in year 2000, and has extensive experience indifferent markets including International Technology Licensing, EngineeringProcurement Construction Services, Specialty Chemicals, Consumer Markets.Chemtex is a leader in chemical engineering and renewable processes. In partnershipwith Texas Pacific Group and Novozymes, Chemtex is starting up a 40,000 metric tonper year bio-refinery in northern Italy that will produce cellulosic ethanol from locallysourced ligno-cellulosic biomass using its PROESA process, as well as “green”electricity.PROESA Process has also been selected by numerous leading green chemistrytechnology providers as the technology platform to produce cellulosic sugars for nextgeneration bio-chemicals. Publicly announced collaborators include Amyris,Genomatica, Codexis and Gevo.Scott A. VittersGeneral Manager, PlantBottle Packaging PlatformThe Coca-Cola Company